Other Species / Isoforms
  NDR2 (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

 HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S14
TTTTFPMSNHTRERV
0 1
NDR2 (human) TTTTFPMSNHTRERV S14
NDR2 (mouse) ATTTFPMsNHtRERV S14-p
NDR2 (rat) under review -
T17
TFPMSNHTRERVTVA
0 1
NDR2 (human) TFPMSNHTRERVTVA T17
NDR2 (mouse) TFPMsNHtRERVTVA T17-p
NDR2 (rat) under review -
Y32-p
KLTLENFySNLILQH
0 1
NDR2 (human) KLTLENFySNLILQH Y32-p
NDR2 (mouse) KLTLENFYSNLILQH Y32
NDR2 (rat) under review -
S68
EEKKLRRSQHARKEt
0 1
NDR2 (human) EEKKLRRSQHARKEt S68
NDR2 (mouse) EEKKLRRsQHARKET S68-p
NDR2 (rat) under review -
T75-p
SQHARKEtEFLRLKR
Upstream
Downstream
2 0
Effects on Modified Protein
  • enzymatic activity, induced
  • molecular association, regulation
Effects on Biological Processes:
  • cell growth, altered
Treatment
  • IGF-1
NDR2 (human) SQHARKEtEFLRLKR T75-p
NDR2 (mouse) sQHARKETEFLRLKR T75
NDR2 (rat) under review -
K94-ub
LDDFESLkVIGRGAF
0 7
NDR2 (human) LDDFESLkVIGRGAF K94-ub
NDR2 (mouse) LDDFESLKVIARGAF K94
NDR2 (rat) under review -
K110-ub
EVRLVQKkDTGHIyA
0 2
NDR2 (human) EVRLVQKkDTGHIyA K110-ub
NDR2 (mouse) EVRLVQKKDTGHIYA K110
NDR2 (rat) under review -
Y116-p
KkDTGHIyAMkILRk
0 1
NDR2 (human) KkDTGHIyAMkILRk Y116-p
NDR2 (mouse) KKDTGHIYAMKILRK Y116
NDR2 (rat) under review -
K119-ub
TGHIyAMkILRkSDM
0 1
NDR2 (human) TGHIyAMkILRkSDM K119-ub
NDR2 (mouse) TGHIYAMKILRKADM K119
NDR2 (rat) under review -
K123-ub
yAMkILRkSDMLEkE
0 1
NDR2 (human) yAMkILRkSDMLEkE K123-ub
NDR2 (mouse) YAMKILRKADMLEKE K123
NDR2 (rat) under review -
K129-ub
RkSDMLEkEQVAHIR
0 1
NDR2 (human) RkSDMLEkEQVAHIR K129-ub
NDR2 (mouse) RKADMLEKEQVAHIR K129
NDR2 (rat) under review -
K215-ub
GFIHRDIkPDNLLLD
0 2
NDR2 (human) GFIHRDIkPDNLLLD K215-ub
NDR2 (mouse) GFIHRDVKPDNLLLD K215
NDR2 (rat) under review -
K224-ub
DNLLLDAkGHVKLSD
0 2
NDR2 (human) DNLLLDAkGHVKLSD K224-ub
NDR2 (mouse) DNLLLDAKGHVKLSD K224
NDR2 (rat) under review -
S265-p
FSFQNMNskRKAETW
0 7
NDR2 (human) FSFQNMNskRKAETW S265-p
NDR2 (mouse) FSFQNMNsKRKAETW S265-p
NDR2 (rat) under review -
K266-ub
SFQNMNskRKAETWK
0 3
NDR2 (human) SFQNMNskRKAETWK K266-ub
NDR2 (mouse) SFQNMNsKRKAETWK K266
NDR2 (rat) under review -
S282-p
NRRQLAYstVGtPDy
Upstream
Downstream
4 9
Effects on Modified Protein
  • enzymatic activity, induced
  • molecular association, regulation
Effects on Biological Processes:
  • cell growth, altered
Putative in vivo kinases:
  • NDR2 (human)
Regulatory protein:
  • CCND1 (human)
  • CDK4 (human)
  • MOB1A (human)
  • MST1 (human)
Treatment
  • IGF-1
  • okadaic_acid
NDR2 (human) NRRQLAYstVGtPDy S282-p
NDR2 (mouse) NRRQLAYsTVGTPDY S282-p
NDR2 (rat) under review -
T283-p
RRQLAYstVGtPDyI
0 9
NDR2 (human) RRQLAYstVGtPDyI T283-p
NDR2 (mouse) RRQLAYsTVGTPDYI T283
NDR2 (rat) under review -
T286-p
LAYstVGtPDyIAPE
0 3
NDR2 (human) LAYstVGtPDyIAPE T286-p
NDR2 (mouse) LAYsTVGTPDYIAPE T286
NDR2 (rat) under review -
Y289-p
stVGtPDyIAPEVFM
0 2
NDR2 (human) stVGtPDyIAPEVFM Y289-p
NDR2 (mouse) sTVGTPDYIAPEVFM Y289
NDR2 (rat) under review -
K378-ub
NSGVEEIkGHPFFEG
0 2
NDR2 (human) NSGVEEIkGHPFFEG K378-ub
NDR2 (mouse) NGGVEEIKGHPFFEG K378
NDR2 (rat) under review -
K403-ub
AAIPIEIkSIDDTSN
0 1
NDR2 (human) AAIPIEIkSIDDTSN K403-ub
NDR2 (mouse) AAIPIEIRSIDDTSN R403
NDR2 (rat) under review -
Y441-p
KDWVFLNytyKRFEG
0 2
NDR2 (human) KDWVFLNytyKRFEG Y441-p
NDR2 (mouse) KDWVFLNYTYKRFEG Y441
NDR2 (rat) under review -
T442-p
DWVFLNytyKRFEGL
Upstream
Downstream
4 10
Effects on Modified Protein
  • enzymatic activity, induced
  • molecular association, regulation
  • phosphorylation
Effects on Biological Processes:
  • cell growth, altered
Kinase, in vitro:
  • MST3 (human)
Putative in vivo kinases:
  • MST3 (human)
Treatment
  • IGF-1
  • okadaic_acid
NDR2 (human) DWVFLNytyKRFEGL T442-p
NDR2 (mouse) DWVFLNYTYKRFEGL T442
NDR2 (rat) under review -
Y443-p
WVFLNytyKRFEGLt
0 5
NDR2 (human) WVFLNytyKRFEGLt Y443-p
NDR2 (mouse) WVFLNYTYKRFEGLT Y443
NDR2 (rat) under review -
T450-p
yKRFEGLtQrGsIPT
0 17
NDR2 (human) yKRFEGLtQrGsIPT T450-p
NDR2 (mouse) YKRFEGLTQRGsIPT T450
NDR2 (rat) under review -
R452-m1
RFEGLtQrGsIPTYM
0 1
NDR2 (human) RFEGLtQrGsIPTYM R452-m1
NDR2 (mouse) RFEGLTQRGsIPTYM R452
NDR2 (rat) under review -
S454-p
EGLtQrGsIPTYMkA
0 3
NDR2 (human) EGLtQrGsIPTYMkA S454-p
NDR2 (mouse) EGLTQRGsIPTYMKA S454-p
NDR2 (rat) under review -
K460-ub
GsIPTYMkAGkL___
0 1
NDR2 (human) GsIPTYMkAGkL___ K460-ub
NDR2 (mouse) GsIPTYMKAGKL___ K460
NDR2 (rat) under review -
K463-ac
PTYMkAGkL______
Upstream
1 0
Treatment
  • nicotinamide
  • trichostatin_A
NDR2 (human) PTYMkAGkL______ K463-ac
NDR2 (mouse) PTYMKAGKL______ K463
NDR2 (rat) under review -